Femtopath citation update: Journal of Thoracic Oncology, Volume 13, Issue 6, 2018.

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Third generation EGFR TKIs: current data and future directions

Pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection

OncoKB: A Precision Oncology Knowledge Base

The cutoff limit of reference intervals for mutant KRAS was determined to be ~ 0.09% based on samples from healthy individuals

Small Cell Carcinoma of the Urinary Bladder and Implications for Diagnosis, Prognosis, and Treatment

AccuQuant DIgital PCR launch at Medica 2017

Mutation enrichment方法學專利保護地區新增歐盟地區

大腸瘜肉基因檢測評估說明